APA

Moreno M., Mol B. M., von Mensdorff-Pouilly S., Verheijen R. H. M., von Blomberg B. M. E., van den Eertwegh A. J. M., Scheper R. J. & Bontkes H. J. (20090707). Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC). : Cancer letters.

Chicago

Moreno María, Mol Berber M, von Mensdorff-Pouilly Silvia, Verheijen René H M, von Blomberg B Mary E, van den Eertwegh Alfons J M, Scheper Rik J and Bontkes Hetty J. 20090707. Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC). : Cancer letters.

Harvard

Moreno M., Mol B. M., von Mensdorff-Pouilly S., Verheijen R. H. M., von Blomberg B. M. E., van den Eertwegh A. J. M., Scheper R. J. and Bontkes H. J. (20090707). Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC). : Cancer letters.

MLA

Moreno María, Mol Berber M, von Mensdorff-Pouilly Silvia, Verheijen René H M, von Blomberg B Mary E, van den Eertwegh Alfons J M, Scheper Rik J and Bontkes Hetty J. Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC). : Cancer letters. 20090707.